ICU Medical, Inc. (FRA:IC7)
| Market Cap | 3.29B -13.3% |
| Revenue (ttm) | 1.90B -6.3% |
| Net Income | 623.44K |
| EPS | 0.03 |
| Shares Out | n/a |
| PE Ratio | 5,278.57 |
| Forward PE | 18.91 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 19 |
| Open | 127.00 |
| Previous Close | 126.00 |
| Day's Range | 127.00 - 131.00 |
| 52-Week Range | 92.00 - 156.00 |
| Beta | n/a |
| RSI | 58.36 |
| Earnings Date | Feb 19, 2026 |
About ICU Medical
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinf... [Read more]
News
ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call
SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of ...
ICU Medical Inc at JPMorgan Healthcare Conference Transcript
ICU Medical Inc at JPMorgan Healthcare Conference Transcript
ICU Medical, Inc. (ICUI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ICU Medical, Inc. (ICUI) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company...
ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company...
ICU Medical: Difficult Transition, A More Interesting Company (Upgrade)
ICU Medical stock is poised for growth and margin gains post-integration. Here's what investors need to know.
ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference
SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company...
Insiders Buy the Holdings of VHT ETF
A look at the weighted underlying holdings of the Vanguard Health Care ETF (VHT) shows an impressive 17.6% of holdings on a weighted basis have experienced insider buying within the past six months. I...
Director Elisha Finney Sells Shares of ICU Medical Inc (ICUI)
Director Elisha Finney Sells Shares of ICU Medical Inc (ICUI)
ICUI Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of ICU Medical Inc (Symbol: ICUI) crossed above their 200 day moving average of $134.84, changing hands as high as $149.48 per share. ICU Medical Inc shares are currently ...
Keybanc Raises Price Target for ICUI, Maintains Overweight Rating | ICUI Stock News
Keybanc Raises Price Target for ICUI, Maintains Overweight Rating | ICUI Stock News
Piper Sandler Raises Price Target for ICUI; Maintains Overweight Rating | ICUI Stock News
Piper Sandler Raises Price Target for ICUI; Maintains Overweight Rating | ICUI Stock News
ICU Medical Inc (ICUI) Q3 2025 Earnings Call Highlights: Strong EPS Growth Amid Revenue Challenges
ICU Medical Inc (ICUI) Q3 2025 Earnings Call Highlights: Strong EPS Growth Amid Revenue Challenges
Q3 Results Spark After-Hours Surge In GMED, TNDM, ICUI, ORGO, SKIN, TXG
(RTTNews) - A wave of earnings releases and revised 2025 guidance triggered strong after-hours gains across several healthcare and life sciences stocks on Thursday.
Q3 2025 ICU Medical Inc Earnings Call Transcript
Q3 2025 ICU Medical Inc Earnings Call Transcript
ICU Medical updates 2025 EPS guidance to $7.35–$7.65 amid strong Q3 growth and cost controls
Get key takeaways from ICU Medical's Q3 2025 earnings call: organic growth, raised guidance, margin gains, and innovation updates.
ICU Medical, Inc. 2025 Q3 - Results - Earnings Call Presentation
ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call November 6, 2025 4:30 PM ESTCompany ParticipantsVivek Jain - CEO & Chairman of the BoardBrian Bonnell -...
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of +31.82% and +3.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
ICU Medical (ICUI) Q3 2025 Earnings Transcript
ICU Medical (ICUI) Q3 2025 Earnings Transcript
ICUI Updates Fiscal Year 2025 Financial Projections
ICUI Updates Fiscal Year 2025 Financial Projections
ICUI Exceeds Revenue Expectations in Q3 Report
ICUI Exceeds Revenue Expectations in Q3 Report
ICU Medical Q3 Earnings Summary
(RTTNews) - Below are the earnings highlights for ICU Medical (ICUI):
ICU Medical Inc (ICUI) Q3 2025 Earnings: Revenue Hits $537M, Adjusted EPS Soars to $2. ...
ICU Medical Inc (ICUI) Q3 2025 Earnings: Revenue Hits $537M, Adjusted EPS Soars to $2.03, Beating Estimates